Article
Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.
Brain pathology (Zurich, Switzerland) - 1 Sept 2024
Lee Boram, Hwang Soohyun, Bae Hyunsik, Choi Kyue-Hee, Suh Yeon-Lim
Abstract excerpt
The accurate diagnosis and classification of gliomas are essential for appropriate treatment planning and prognosis prediction. This study aimed to investigate the molecular diagnostics of IDH-wildtype diffuse astrocytic gliomas and identify potential genetic variants that could differentiate glioblastoma (GBM) from lower-grade gliomas when DNA methylation analysis is not feasible. In total, 479 H3-and...
Topics
- Humans
- Male
- Female
- Middle Aged
- Brain Neoplasms
- Adult
- Isocitrate Dehydrogenase
- Glioblastoma
- Glioma
- Aged
- High-Throughput Nucleotide Sequencing
